High peptide affinity for MHC class I does not correlate with immunodominance

Scandinavian Journal of Immunology

Volumn 50, Issue 4, 1999, Pages 420-426

  Mullbacher A ^a   Lobigs, M ^a   Yewdell, J W ^b   Bennink, J R ^b   Tha Hla, R ^a   Blanden, R V ^a  

^a Biology and Environment   (Australia)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; GLUTAMINE; HISTIDINE; VIRUS NUCLEOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; FLUORESCENCE ACTIVATED CELL SORTER; IMMUNOSTIMULATION; INFLUENZA VIRUS; LYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; H-2 ANTIGENS; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MUTATION; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS;

EID: 0032880423     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00619.x     Document Type: Article

References (26)

1. Hill AB, Müllbacher A, Blanden RV. Ir genes, peripheral cross-tolerance and immunodominance in MHC class I restricted T cell responses; an old quagmire revisited. Immunol Rev 1993;133:75-91.
2. Müllbacher A, Sheena JH, Fierz W, Brenan M. Specific haplotype preference in congenic Fl hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y. J Immunol 1981;127:686-9.
3. Müllbacher A, Blanden R, Brenan M. Neonatal tolerance to MHC antigens alters Ir gene control of the cytotoxic T cell response to vaccinia virus. J Exp Med 1983;157:1324-38.
4. Wettstein PJ, Bailey DW. Immunodominance in the immune response to 'multiple' histocompatibility antigens. Immunogenetics 1982;16:47-53.
5. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-18.
6. Bjorkman PJ, Davis MM. Model for the interaction of T-cell receptors with peptide/MHC complex. Cold Spring Harbor Symposium Quant Biol 1989;54:365-73.
7. Rötzschke O, Falk K, Deres K, et al. Isolation and analysis of naturally processed viral peptides as recognised by cytotoxic T cells. Nature 1990;348:252-4.
8. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.
9. Falk K, Rötzschke O, Rammensee H-G. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990;348:248-51.
10. Restifo NP, Esquivel F, Kawakami Y, et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-72.
11. d antigen expressed by recombinant vaccinia virus. Proc Natl Acad Sci USA 1986;83:7879-82.
12. Eisenlohr LC, Yewdell JW, Bennink JR. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 1992;175:481-7.
13. Andrew ME, Coupar BEH, Boyle DB, Blanden RV. Recognition by major histocompatibility complex class I-restricted cytolytic T lymphocytes of cells expressing vaccinia-encoded viral and class I proteins. Eur J Immunol 1987;17:1515-18.
14. Müllbacher A, Hill AB, Blanden RV, Cowden WB, King NJC, Tha Hla R. Alloreactive cytotoxic T cells recognise MHC class I antigen without peptide specificity. J Immunol 1991;147:1765-72.
15. Kesson AM, Blanden RV, Müllbacher A. The primary in vivo murine cytotoxic T cell response to the flaviviurs, West Nile. J Gen Virol 1987;68:2001-6.
16. Kesson AM, Blanden RV, Müllbacher A. The secondary in vitro murine cytotoxic T-cell response to the flavivirus, West Nile. Immunol Cell Biol 1988;66:23-32.
17. Müllbacher A, Blanden RV. Crossreactivity patterns of murine cytotoxic T lymphocytes. Cell Immunol 1979;43:70-81.
18. Bacik I, Cox JH, Anderson R, Yewdell JW, Bennink JR. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J Immunol 1994;152:381-7.
19. Deng Y, Yewdell JW, Eisenlohr LC, Bennink JR. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol 1997;158:1507-15.
20. + T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol 1994;153:4636-48.
21. Wysocka m, Bennink JR. Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products. Cell Immunol 1988;112:425-9.
22. d affects cytotoxic T cell responses to influenza virus infection. Eur J Immunol 1999;29:1-7.
23. Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986;5:943-9.
24. Rammensee H-GKF, Rötzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993;11:213-44.
25. d histocompatibility antigen. Nucleic Acid Res 1983;11:1567-77.
26. d molecules with different peptide profiles. J Immunol 1996;157:2455-61.